2cm8: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Crystal structures of protein-tyrosine phosphatase 1B in complex with, compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate, mimetic reveal that the heterocycle is highly complementary to the, catalytic pocket of the protein. The heterocycle participates in an, extensive network of hydrogen bonds with the backbone of the, phosphate-binding loop, Phe(182) of the flap, and the side chain of, Arg(221). When substituted with a phenol, the small inhibitor induces the, closed conformation of the protein and displaces all waters in the, catalytic pocket. Saturated IZD-containing peptides are more potent, inhibitors than unsaturated analogs because the IZD heterocycle and phenyl, ring directly attached to it bind in a nearly orthogonal orientation with, respect to each other, a conformation that is close to the energy minimum, of the saturated IZD-phenyl moiety. These results explain why the, heterocycle is a potent phosphonate mimetic and an ideal starting point, for designing small nonpeptidic inhibitors.
Crystal structures of protein-tyrosine phosphatase 1B in complex with compounds bearing a novel isothiazolidinone (IZD) heterocyclic phosphonate mimetic reveal that the heterocycle is highly complementary to the catalytic pocket of the protein. The heterocycle participates in an extensive network of hydrogen bonds with the backbone of the phosphate-binding loop, Phe(182) of the flap, and the side chain of Arg(221). When substituted with a phenol, the small inhibitor induces the closed conformation of the protein and displaces all waters in the catalytic pocket. Saturated IZD-containing peptides are more potent inhibitors than unsaturated analogs because the IZD heterocycle and phenyl ring directly attached to it bind in a nearly orthogonal orientation with respect to each other, a conformation that is close to the energy minimum of the saturated IZD-phenyl moiety. These results explain why the heterocycle is a potent phosphonate mimetic and an ideal starting point for designing small nonpeptidic inhibitors.


==Disease==
==Disease==
Line 17: Line 17:
[[Category: Protein-tyrosine-phosphatase]]
[[Category: Protein-tyrosine-phosphatase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ala, P.J.]]
[[Category: Ala, P J.]]
[[Category: Becker-Pasha, M.]]
[[Category: Becker-Pasha, M.]]
[[Category: Bower, M.]]
[[Category: Bower, M.]]
[[Category: Burn, T.C.]]
[[Category: Burn, T C.]]
[[Category: Combs, A.P.]]
[[Category: Combs, A P.]]
[[Category: Douty, B.]]
[[Category: Douty, B.]]
[[Category: Gonneville, L.]]
[[Category: Gonneville, L.]]
[[Category: Hillman, M.C.]]
[[Category: Hillman, M C.]]
[[Category: Hollis, G.F.]]
[[Category: Hollis, G F.]]
[[Category: Klabe, R.]]
[[Category: Klabe, R.]]
[[Category: Polam, P.]]
[[Category: Polam, P.]]
[[Category: Reid, B.G.]]
[[Category: Reid, B G.]]
[[Category: Wasserman, Z.]]
[[Category: Wasserman, Z.]]
[[Category: Wayland, B.]]
[[Category: Wayland, B.]]
[[Category: Wei, M.]]
[[Category: Wei, M.]]
[[Category: Wynn, R.]]
[[Category: Wynn, R.]]
[[Category: Yue, E.W.]]
[[Category: Yue, E W.]]
[[Category: F16]]
[[Category: F16]]
[[Category: MG]]
[[Category: MG]]
Line 44: Line 44:
[[Category: protein phosphatase]]
[[Category: protein phosphatase]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:36:53 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:50:06 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA